Technical agreements on biocides (TABs) provide general agreements of the Working Groups of the Committee on Biocidal Products (MFIs) in a concise form, which are not yet included in other BPR guidelines. This document presents a general database containing issues on which agreement has been reached. The general relevance focuses on methodological decisions on risk assessment and on issues relating to the implementation of The Biocides Regulation 528/2012. Tab entries concerning editorial changes to existing guidelines or entries precipitating existing guidelines apply from the date of publication. However, the approach taken in the PCB document, which is called the time frame for the application of the new guidelines and guidance documents in the approval of the active substance or in the CA-July12-Doc.6.2d (products) document, should be followed for tab entries requiring new data. The deadline is six months (active substance) or two years (products) before the date of submission of a first application and three and a half years before the expiry of the current application in the event of an extension, unless scientific progress shows that the invocation of old guidelines is of concern. 5.4. In situ production of biocides and active substances In addition to the BPR guidelines and tab agreements, there are also relevant CA documents that should be used for the scientific evaluation of the different aspects. A list of finished CA documents is available on CIRCABC (Part of the European Commission > Health and Food Safety>Biozide – BPR 528/2012 – Public > Library > Documents finalised at CA meetings).

New elements (BPRs) relating to technical and scientific assessment that do not relate to a specific aspect, such as physical chemistry, efficacy, human toxicology and the environment, are described below (e.g. BPF, SoC, etc.). Relevant CA documents by aspect are presented for that specific aspect. The working groups shall carry out scientific and technical peer reviews and discuss other relevant scientific and technical issues under the Biocidal Products Regulation. .